Search research articles
Contact Us
Filters
Showing results (721-730 of 928) with videos related to
Page
of 93
Sort By:
The Journal of Clinical Investigation
|
November 18, 2014
Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1
Ziad A Ali, Vinicio de Jesus Perez, Ke Yuan, et al.
Nature Genetics
|
July 13, 2010
Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction
Connie R Bezzina, Raha Pazoki, Abdennasser Bardai, et al.
The Lancet. Diabetes & Endocrinology
|
July 6, 2019
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Kausik K Ray, Helen M Colhoun, Michael Szarek, et al.
Scientific Reports
|
November 6, 2020
An individual participant data analysis of prospective cohort studies on the association between subclinical thyroid dysfunction and depressive symptoms
Lea Wildisen, Cinzia Del Giovane, Elisavet Moutzouri, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes
Maddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
BMC Endocrine Disorders
|
February 5, 2017
Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST)
David J Stott, Jacobijn Gussekloo, Patricia M Kearney, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
Nicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Journal of the American College of Cardiology
|
September 20, 2005
Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention
Pascalle S Monraats, Jamal S Rana, Melchior C Nierman, et al.
Diabetes
|
May 22, 2016
Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease
Hanieh Yaghootkar, Luca A Lotta, Jessica Tyrrell, et al.
Human Molecular Genetics
|
September 1, 2011
A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention
M Lourdes Sampietro, Stella Trompet, Jeffrey J W Verschuren, et al.
Page
of 93
Search research articles
Search
Showing results (721-730 of 928) with videos related to
Sort By:
Page
of 93
The Journal of Clinical Investigation
|
November 18, 2014
Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1
Ziad A Ali, Vinicio de Jesus Perez, Ke Yuan, et al.
Nature Genetics
|
July 13, 2010
Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction
Connie R Bezzina, Raha Pazoki, Abdennasser Bardai, et al.
The Lancet. Diabetes & Endocrinology
|
July 6, 2019
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Kausik K Ray, Helen M Colhoun, Michael Szarek, et al.
Scientific Reports
|
November 6, 2020
An individual participant data analysis of prospective cohort studies on the association between subclinical thyroid dysfunction and depressive symptoms
Lea Wildisen, Cinzia Del Giovane, Elisavet Moutzouri, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 23, 2017
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes
Maddalena Lettino, Pontus Andell, Uwe Zeymer, et al.
BMC Endocrine Disorders
|
February 5, 2017
Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST)
David J Stott, Jacobijn Gussekloo, Patricia M Kearney, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
Nicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Journal of the American College of Cardiology
|
September 20, 2005
Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention
Pascalle S Monraats, Jamal S Rana, Melchior C Nierman, et al.
Diabetes
|
May 22, 2016
Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease
Hanieh Yaghootkar, Luca A Lotta, Jessica Tyrrell, et al.
Human Molecular Genetics
|
September 1, 2011
A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention
M Lourdes Sampietro, Stella Trompet, Jeffrey J W Verschuren, et al.
Page
of 93